The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review.
about
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerReinventing diagnostics for personalized therapy in oncologyA laboratory prognostic index model for patients with advanced non-small cell lung cancerIndividual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy.Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results ProgramThe role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study.Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapy.Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.NOTCH1, HIF1A and other cancer-related proteins in lung tissue from uranium miners--variation by occupational exposure and subtype of lung cancerA transcriptional network signature characterizes lung cancer subtypesA combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trialPrognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysisPredictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer.MicroRNA expression differentiates histology and predicts survival of lung cancer.Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.Biomarkers and targeted systemic therapies in advanced non-small cell lung cancerUtility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesTailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft modelsThe deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis.Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.Clinical outcomes in non-small-cell lung cancer in relation to expression of predictive and prognostic biomarkers.Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancerHistology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.Personalized medicine for lung cancer: new challenges for pathology.Management of advanced lung cancer in resource-constrained settings: a perspective from India.Biomarkers of bone turnover in oncology: applications in diagnosis and treatment.Histo-cytological diagnostic accuracy in lung cancer.Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvementCharacterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.Current status of research and treatment for non-small cell lung cancer in never-smoking females.Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.
P2860
Q26865662-7FBE4DF7-289D-4E91-98E7-1B786CDECEE2Q28391395-FF97651A-DB0E-41B3-84DB-B5A9E4FF95D0Q28542513-39E8E0B2-E067-40AD-AFB2-832692804FCDQ30833179-A016B6B8-B6B9-4CAB-AB03-783A929CBE2EQ33396369-6B907E06-13E5-46B8-A1D1-75F46ECC9368Q33909900-B3921554-8559-461D-BB05-D2995A114653Q33994360-00BBBB4F-6C94-411E-BF32-B3E059D703A2Q34005272-63FDED6B-244F-4668-83F8-3983799E89BDQ34109148-801B4F81-E6C4-4A5E-B3C6-1506B6E5F772Q34262527-8572FBC4-AD96-4D2A-AB86-E049D98BBC1FQ34428676-761F901A-145A-463A-8E47-2A541D7ACEEEQ34472310-9DE5F2D3-9C18-4FB5-9CC0-66514DBFBCDEQ34747013-A6DD35CC-C125-4E5B-949B-7FE79E034973Q35040775-0DC4F3F5-02A4-4EDB-A6CB-D01ED540B20AQ35076206-18714E67-AD4B-4579-8876-38314C1F542BQ35184912-79CA75A4-C679-4F17-8CEB-D189F1E2C595Q35692115-A247954C-B31F-4084-8F6C-71E18D05A64FQ35919451-0ADA20D6-B37F-47BB-A2E5-806FFB2CDE65Q36260477-4F26F5DB-FE72-4DF1-9BE9-B786A1183C14Q36320798-D55981D0-5410-4F05-9ACE-41BBFA7EAF8CQ36412597-7AC55486-7570-4CF9-95BD-249FA3D769E2Q36441443-D8B9B016-9FD2-4F47-B412-ED401A0E8479Q36448279-E8B86B8E-71B6-49C0-8246-2B1CF39CD36EQ37381637-DA6C8651-6F13-4CED-9313-50429835F740Q37388593-624D10BF-4631-414F-B9A0-F9FBDD08B120Q37449024-996EF63B-4871-4626-B4B5-D9357F7062ECQ37483162-9B5887DD-1403-458C-8C5F-752B9EF3BEB5Q37695838-AFBC0A99-4172-44EA-A224-1795F35944C4Q37750786-1035FAB2-3DBD-4CE8-A6E6-FF37BEF3D910Q37892932-FE12A58F-CE0B-4449-A37A-D151BC8A6090Q37908174-85D1C435-04F7-465A-88CB-F94181972E9AQ37932029-93ADD225-CBEB-4C44-8760-D9E5BEE70165Q38068210-F002B1F3-602B-41CE-A6F8-422681A7B481Q38088714-77F27C8C-F0FA-435C-BE09-C9A05B69DEA5Q38164052-0825F21A-8380-4A28-B390-7E88FFEE537EQ38437389-0DD9A996-33CD-4CAA-B613-B9ACE7D80DE7Q38842969-B0A9FCBA-B52A-4D0F-9A20-593B4EF82F67Q38999884-5D578526-EF94-48C8-97E2-BC5FE102CA3AQ39298725-CABEA728-73CA-460A-9C85-1D5F703BA612Q39617870-BED2E569-B45E-4FDD-84E2-4BD16BD99E02
P2860
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic and predictive ...... g cancer: a literature review.
@en
The prognostic and predictive ...... g cancer: a literature review.
@nl
type
label
The prognostic and predictive ...... g cancer: a literature review.
@en
The prognostic and predictive ...... g cancer: a literature review.
@nl
prefLabel
The prognostic and predictive ...... g cancer: a literature review.
@en
The prognostic and predictive ...... g cancer: a literature review.
@nl
P2093
P1476
The prognostic and predictive ...... g cancer: a literature review.
@en
P2093
Anna Spreafico
Fred R Hirsch
Lorinda Simms
Mary Dugan Wood
Mauro Papotti
Silvia Novello
P304
P356
10.1097/JTO.0B013E318189F551
P577
2008-12-01T00:00:00Z